✨ Medicines Act Notices




2870 NEW ZEALAND GAZETTE, No. 97 17 AUGUST 2006

Medicines Act 1981

Consent to the Distribution of New Related Products

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:

Schedule

Product: Head & Shoulders Anti-Dandruff Conditioner – Natural Shine
Active Ingredient: Pyrithione zinc 0.5%w/v
Dosage Form: Scalp lotion
New Zealand Sponsor: Procter & Gamble Distributing New Zealand
Manufacturer: Procter & Gamble Manufacturing (Thailand) Limited, Wellgrow Industrial Estate, Bangkpakong, Chacheonsao, Thailand

Product: Head & Shoulders Anti-Dandruff Shampoo – Natural Shine
Active Ingredient: Pyrithione zinc 1%w/v
Dosage Form: Shampoo
New Zealand Sponsor: Procter & Gamble Distributing New Zealand
Manufacturer: Procter & Gamble Manufacturing (Thailand) Limited, Wellgrow Industrial Estate, Bangkpakong, Chacheonsao, Thailand

Dated this 10th day of August 2006.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go5558

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Avelox IV 400
Active Ingredient: Moxifloxacin hydrochloride 436.8mg equivalent to 400mg moxifloxacin
Dosage Form: Solution for infusion
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturer: Bayer Healthcare AG, Bayerwerk, Germany

Product: Avelox
Active Ingredient: Moxifloxacin hydrochloride 436.8mg equivalent to 400mg moxifloxacin
Dosage Form: Film coated tablet
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturer: Bayer Healthcare AG, Bayerwerk, Germany

Product: Modavigil
Active Ingredient: Modafinil 100mg
Dosage Form: Tablet
New Zealand Sponsor: CSL New Zealand Limited
Manufacturers: Laboratoires Macors, Zone Industrielle de la Plaine des Isles, Auxerre, France
Laboratoires Opodex Industrie, Saint-Denis, Villeneuve la Garenne, (Hauts-de-Seine), France

Dated this 10th day of August 2006.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go5559

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: OxyNorm
Active Ingredient: Oxycodone hydrochloride 10mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Mundipharma New Zealand Limited
Manufacturer: BCM Limited, Nottingham, United Kingdom



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2006, No 97


Gazette.govt.nz PDF NZ Gazette 2006, No 97





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of New Related Products

πŸ₯ Health & Social Welfare
10 August 2006
Medicines, Distribution, Head & Shoulders, Pyrithione zinc
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Consent to Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
10 August 2006
Medicines, Distribution, Avelox, Modavigil, Moxifloxacin, Modafinil
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
10 August 2006
Medicines, Distribution, OxyNorm, Oxycodone
  • DON MATHESON, Deputy Director-General, Public Health